ENTRY       D02297            Mixture   Drug
NAME        Emtricitabine and tenofovir disoproxil;
            Truvada (TN)
PRODUCT     TRUVADA (Bryant Ranch Prepack)
            TRUVADA (Gilead Sciences)
            TRUVADA (RedPharm Drug)
  GENERIC   EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (A-S Medication Solutions)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (A-S Medication Solutions)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (American Health Packaging)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Amneal Pharmaceuticals NY LLC)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Amneal Pharmaceuticals NY LLC)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Amneal Pharmaceuticals NY LLC)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Apotex Corp.)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Aurobindo Pharma Limited)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Aurobindo Pharma Limited)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (AvKARE)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Camber Pharmaceuticals)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Cipla USA)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Cipla USA)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (DIRECT RX)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Direct Rx)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (DirectRx)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Exelan Pharmaceuticals)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Golden State Medical Supply)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Laurus Labs Limited)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Lupin Pharmaceuticals)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Macleods Pharmaceuticals Limited)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Major Pharmaceuticals)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Mylan Pharmaceuticals)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (NorthStar RxLLC)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Pharmasource Meds)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Pharmasource Meds)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Proficient Rx LP)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (QUALLENT PHARMACEUTICALS HEALTH LLC)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (RPK Pharmaceuticals)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Redpharm Drug)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Redpharm Drug)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Redpharm Drug)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Strides Pharma Science Limited)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Teva Pharmaceuticals USA)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Zydus Lifesciences Limited)
            EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (Zydus Pharmaceuticals USA)
            EMTRICITABINE/TDF (Direct_Rx)
COMPONENT   Emtricitabine [DR:D01199], (Tenofovir disoproxil fumarate [DR:D01982] | Tenofovir disoproxil phosphate [DR:D10834])
CLASS       Antiviral
             DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
             DG03107  Anti-HIV agent
REMARK      Therapeutic category: 6250
            ATC code: J05AR03
            Product: D02297<JP/US>
EFFICACY    Antiviral
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AR Antivirals for treatment of HIV infections, combinations
                 J05AR03 Tenofovir disoproxil and emtricitabine
                  D02297  Emtricitabine and tenofovir disoproxil &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Combinations
               Emtricitabine/ Tenofovir Disoproxil Fumarate
                D02297  Emtricitabine and tenofovir disoproxil
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D02297  Emtricitabine and tenofovir disoproxil
            Drug groups [BR:br08330]
             Antiviral
              DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
               D02297  Emtricitabine and tenofovir disoproxil
              DG03107  Anti-HIV agent
               D02297  Emtricitabine and tenofovir disoproxil
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D02297  Emtricitabine and tenofovir disoproxil
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D02297  Emtricitabine and tenofovir disoproxil &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D02297
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D02297
DBLINKS     PubChem: 7849356
///
